U.S. flag

An official website of the United States government

NM_000159.4(GCDH):c.1199dup (p.Ile401fs) AND Glutaric aciduria, type 1

Germline classification:
Pathogenic/Likely pathogenic (3 submissions)
Last evaluated:
Dec 22, 2023
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001377483.7

Allele description

NM_000159.4(GCDH):c.1199dup (p.Ile401fs)

Gene:
GCDH:glutaryl-CoA dehydrogenase [Gene - OMIM - HGNC]
Variant type:
Duplication
Cytogenetic location:
19p13.13
Genomic location:
Preferred name:
NM_000159.4(GCDH):c.1199dup (p.Ile401fs)
HGVS:
  • NC_000019.10:g.12897819dup
  • NG_009292.1:g.11660dup
  • NG_033049.1:g.26454dup
  • NM_000159.4:c.1199dupMANE SELECT
  • NM_013976.5:c.1199dup
  • NP_000150.1:p.Ile401fs
  • NP_039663.1:p.Ile401fs
  • NC_000019.9:g.13008632_13008633insT
  • NC_000019.9:g.13008633dup
  • NM_000159.2:c.1199dupT
  • NR_102316.1:n.1362dup
  • NR_102317.1:n.1580dup
Protein change:
I401fs
Links:
dbSNP: rs1970722328
NCBI 1000 Genomes Browser:
rs1970722328
Molecular consequence:
  • NM_000159.4:c.1199dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_013976.5:c.1199dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NR_102316.1:n.1362dup - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_102317.1:n.1580dup - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:
Glutaric aciduria, type 1
Synonyms:
GA I; Glutaryl-CoA dehydrogenase deficiency; Glutaric acidemia type I; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0009281; MedGen: C0268595; Orphanet: 25; OMIM: 231670

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001574824Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Dec 22, 2023)
germlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

SCV002086995Natera, Inc.
no assertion criteria provided
Likely pathogenic
(Apr 8, 2021)
germlineclinical testing

SCV004198744Baylor Genetics
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenic
(Oct 28, 2023)
unknownclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing
not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

The human glutaryl-CoA dehydrogenase gene: report of intronic sequences and of 13 novel mutations causing glutaric aciduria type I.

Schwartz M, Christensen E, Superti-Furga A, Brandt NJ.

Hum Genet. 1998 Apr;102(4):452-8.

PubMed [citation]
PMID:
9600243

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818
See all PubMed Citations (3)

Details of each submission

From Invitae, SCV001574824.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)

Description

This sequence change creates a premature translational stop signal (p.Ile401Aspfs*18) in the GCDH gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 38 amino acid(s) of the GCDH protein. This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with GCDH-related conditions. ClinVar contains an entry for this variant (Variation ID: 1066472). This variant disrupts a region of the GCDH protein in which other variant(s) (p.Ala433Glu) have been determined to be pathogenic (PMID: 9600243; Invitae). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Natera, Inc., SCV002086995.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Baylor Genetics, SCV004198744.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Jun 9, 2024